Senti Biosciences Inc (SNTI)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.33-2.49%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · SNTI
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | — | 0.0 | — | 2.6 | 4.3 | 2.8 | — |
| Total Revenues | — | — | — | 2.6 | 4.3 | 2.8 | — |
| Operating Expenses & Income | |||||||
| R&D Expenses | 31.3 | 37.6 | 34.4 | 32.2 | 28.1 | 22.0 | — |
| Operating Income | (54.7) | (68.8) | (61.0) | (92.7) | (62.1) | (40.4) | — |
| Earnings from Continuing Operations | |||||||
| Other Non-Operating Income / Expenses | 5.1 | 7.3 | 8.2 | 9.3 | 12.4 | (14.9) | — |
| Asset Writedown | — | 5.1 | 0.3 | 26.0 | 0.0 | 0.0 | — |
| Net Income | |||||||
| Net Income | (49.6) | (61.4) | (52.8) | (71.1) | (58.2) | (55.3) | — |
| Per Share | |||||||
| Basic EPS | (1.59) | (2.73) | (12.03) | (16.01) | (2.23) | (19.00) | — |
| Diluted EPS | (1.59) | (2.73) | (12.03) | (16.01) | (2.23) | (19.00) | — |
| Basic Weighted Avg Shares | 31.1 | 22.5 | 4.6 | 4.4 | 26.1 | 2.9 | — |
| Diluted Weighted Avg Shares | 31.1 | 22.5 | 4.6 | 4.4 | 26.1 | 2.9 | — |
| Supplemental | |||||||
| EBIT | (54.7) | (68.8) | (61.0) | (92.7) | (62.1) | (40.4) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.